Altadena, CA, United States of America

Wei Li

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2011-2022

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations of Wei Li in Cancer Treatment

Introduction

Wei Li is an accomplished inventor based in Altadena, California. He has made significant contributions to the field of cancer treatment, holding a total of six patents. His work primarily focuses on developing compositions and methods that target specific cancer types, particularly those over-expressing HIF-1a.

Latest Patents

Wei Li's latest patents include innovative compositions and methods for treating HIF-1a over-expressing cancers. These patents describe monoclonal antibodies that specifically bind to Hsp90α, which are utilized in treating cancers such as breast cancer and lung cancer. The monoclonal antibodies target specific epitopes, including TKPIWTRNP and VKHFSVEGQ, in Hsp90α, providing a novel approach to cancer therapy.

Career Highlights

Wei Li is affiliated with the University of Southern California, where he continues to advance his research and development efforts. His work has garnered attention for its potential to improve treatment outcomes for patients suffering from aggressive forms of cancer.

Collaborations

Some of Wei Li's notable coworkers include Mei Chen and David Woodley, who contribute to his research initiatives and collaborative projects.

Conclusion

Wei Li's innovative work in cancer treatment exemplifies the impact of targeted therapies in modern medicine. His contributions through patents and collaborations highlight the importance of research in combating complex diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…